Chrysalyne D Schmults Selected Research

cemiplimab

2/2021	Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma.
1/2021	Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis.
1/2020	Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
1/2020	Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing.
1/2019	Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma.
1/2018	PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chrysalyne D Schmults Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 11/2009
18	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2009
10	Skin Neoplasms (Skin Cancer) 01/2022 - 11/2009
4	Melanoma (Melanoma, Malignant) 01/2022 - 11/2018
3	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2019
2	Actinic Keratosis 10/2021 - 11/2012
2	Pain (Aches) 01/2021 - 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 06/2022
1	Carcinogenesis 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2021
1	Hutchinson's Melanotic Freckle (Lentigo Maligna) 12/2020
1	Cicatrix (Scar) 07/2019
1	Keratoacanthoma 07/2019
1	Lymphatic Metastasis 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Merkel Cell Carcinoma 01/2018
1	Lymphadenopathy 01/2018
1	Benign Fibrous Histiocytoma (Dermatofibroma) 01/2015
1	Eccrine Porocarcinoma 07/2012
1	Infections 10/2010

Drug/Important Bio-Agent (IBA)

6	cemiplimabIBA 02/2021 - 01/2018
4	Fluorouracil (Carac)FDA LinkGeneric 10/2021 - 01/2016
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2018
3	Imiquimod (Aldara)FDA LinkGeneric 01/2018 - 11/2009
2	Acitretin FDA Link 10/2021 - 01/2021
1	5-hydroxymethylcytosineIBA 01/2022
1	CarcinogensIBA 01/2022
1	CytosineIBA 01/2022
1	EnzymesIBA 01/2022
1	ParaffinIBA 01/2021
1	cyclopropapyrroloindoleIBA 11/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	IpilimumabIBA 11/2018
1	3-ingenyl angelateIBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Sirolimus (Rapamycin)FDA Link 05/2016
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2016
1	Interleukin-2 (IL2)IBA 07/2013
1	CytokinesIBA 07/2013
1	Interleukin-15 (Interleukin 15)IBA 07/2013
1	denileukin diftitox (Ontak)FDA Link 07/2013
1	Chemokine ReceptorsIBA 11/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2012
1	E-SelectinIBA 11/2012
1	LigandsIBA 11/2012
1	CC ChemokinesIBA 11/2012
1	DefensinsIBA 11/2012
1	Granzymes (Granzyme)IBA 11/2009
1	PerforinIBA 11/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2009
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2009
1	Interleukin-10 (Interleukin 10)IBA 11/2009
1	Toll-Like Receptor 7IBA 11/2009

Therapy/Procedure

15	Therapeutics 10/2021 - 11/2009
12	Mohs Surgery (Mohs' Micrographic Surgery) 06/2022 - 01/2009
7	Radiotherapy 01/2021 - 11/2010
3	Immunotherapy 11/2020 - 01/2019
2	Cryotherapy (Therapy, Cold) 10/2021 - 12/2017
2	Dermatologic Surgical Procedures 01/2021 - 05/2014
1	Salvage Therapy 01/2021
1	Chemoprevention 01/2018
1	Adjuvant Chemotherapy 01/2018
1	Organ Transplantation 01/2017
1	Transplantation 01/2017
1	Liver Transplantation 05/2016
1	Curettage 01/2016
1	Photochemotherapy (Photodynamic Therapy) 01/2016